HEIDELBERG PHARMA AG O.N./ DE000A11QVV0 /
2024-09-09 5:36:20 PM | Chg. - | Volume | Bid9:10:36 AM | Ask9:20:07 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
2.460EUR | - | 11,551 Turnover: 28,015.020 |
2.400Bid Size: 949 | 2.470Ask Size: 791 | 84.07 mill.EUR | 0.00% | - |
Assets
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 1.1000 | 1 | 1.3000 | 1.3000 | 1.9000 | ||||||
Intangible Assets | 2.9000 | 2.9000 | 2.8000 | 2.8000 | 2.8000 | ||||||
Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Fixed Assets | 12.1000 | 10 | 10.3000 | 10.3000 | 10.9000 | ||||||
Inventories | .2000 | .3000 | .2000 | .2000 | .2000 | ||||||
Accounts Receivable | .2000 | .4000 | .0900 | .3000 | .4000 | ||||||
Cash and Cash Equivalents | 2.2000 | 1.3000 | 4.6000 | 30.4000 | 19.4000 | ||||||
Current Assets | 2.9000 | 2.1000 | 5 | 31.2000 | 20.3000 | ||||||
Total Assets | 15 | 12.1000 | 15.2000 | 41.5000 | 31.2000 |
Liabilities
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | .3000 | .3000 | .1000 | 1.5000 | .4000 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | 0.0000 | 0.0000 | 3.7000 | 0.0000 | 0.0000 | ||||||
Provisions | - | - | .4000 | .4000 | - | ||||||
Liabilities | 3.2000 | 2.6000 | 5.5000 | 4.5000 | 5.3000 | ||||||
Share Capital | 7.8190 | 9.3060 | 12.9280 | 22.4530 | 28.1330 | ||||||
Total Equity | 11.9000 | 9.5000 | 9.8000 | 37 | 25.9000 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 15 | 12.1000 | 15.2000 | 41.5000 | 31.2000 |
Income Statement
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 5 | 3.9000 | 2.7000 | 1.9000 | 3.7000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -5.6000 | -6.5000 | -6.4000 | -10.8000 | -11.7000 | ||||||
Interest Income | -.0300 | .0030 | -.0190 | -.2000 | - | ||||||
Income Before Taxes | -5.6000 | -6.5000 | -6.4000 | -11 | -11.7000 | ||||||
Income Taxes | .0900 | .0400 | 0.0000 | 0.0000 | 0.0000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Net Income | -5.7000 | -6.6000 | -6.4000 | -11 | -11.7000 |
Per Share
Cash Flow
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -6.6000 | -4.8000 | -6.5000 | -7.9000 | -9.9000 | ||||||
Cash Flow from Investing Activities | -.2000 | -.2000 | -.5000 | -.4000 | -1 | ||||||
Cash Flow from Financing | -.0400 | 4.1000 | 10.3000 | 34.2000 | 0.0000 | ||||||
Decrease / Increase in Cash | -6.7000 | -.9000 | 3.3000 | 25.8000 | -10.9000 | ||||||
Employees | 52 | 55 | 53 | 58 | 62 |